We are pleased to share information regarding newly published review article on the role of immunotherapy in managing new onset refractory status epilepticus. The article, titled “Second-line Immunotherapy in New Onset Refractory Status Epilepticus” by Aurélie Hanin, Eyal Muscal, Lawrence J. Hirsch, was released on March 2 in the journal Epilepsia. This publication comes highly recommended by the ILAE for its insightful contributions to the field.
Author: pdzianok
Categories
ILAE: new job opportunity
We are excited to share information regarding a new job opportunity at ILAE: the position of ILAE Clinical Practice Guideline and Consensus Recommendations Methodologist. For further details on this opening, including the tasks involved, job description, and opportunities for professional development, please refer to the ILAE website. Kindly note that the deadline for applications is April 5, 2024
Categories
CONy 2024 Congress
We are thrilled to extend our invitation to you for the 18th World Congress on Controversies in Neurology (CONy), that will take place on March 21-23, 2024, in the dynamic and culturally rich city of London, UK.
CONy serves as a vital platform for global experts to convene, exchange insights, and engage in constructive discourse, bridging the divide between the advancement of knowledge and its practical application. With its distinctive format centered around debate and discussion, the congress has evolved into a prominent annual gathering for the neurological community.
More information can be found here.
Categories
9th London-Innsbruck Colloquium
You are cordially invited to attend the 9th London-Innsbruck Colloquium on Status Epilepticus and Acute Seizures.
These gatherings have been convened biennially since 2007, and the upcoming colloquium is scheduled to take place from April 8 to 10, 2024, in London. Online participation is also an option.
Preceding the main conference, a workshop titled the 3rd European Course on Continuous EEG in Intensive Care will be conducted.
To register for the event and submit abstracts, please visit www.statusepilepticus.eu. Early registration rates are applicable until January 31, 2024.
Epileptic Disorders™, the educational e-journal of the ILAE, is currently inviting exceptional EEG and/or clinical fellows in epilepsy or senior residents in adult/child neurology to undertake a 6-month term as Interns for Epileptic Disorders™, commencing in January 2024. The deadline for applications is December 1, 2023.
Information on recruitment and requirements can be found on the ILAE website.
Categories
XXXII PTE Conference on Epilepsy
We would like to inform you about the organization of the XXXII PTE Conference on Epilepsy, which will be held in Warsaw on April, 25-27 2024.
More information about the conference is coming soon!
Categories
ILAE: Call for Editors
We share the information posted on the ILAE website:
“The ILAE is looking for a new Editor in Chief for Epilepsia® and a new Editor in Chief for Epilepsia Open®. The two current editors complete their terms on 1 September 2024. Please review the duties of the editor before submitting an application, and kindly note that it is possible to apply for both positions.”
Application forms: Epilepsia Editor in Chief | Epilepsia Open Editor in Chief
Deadline: 15 December 2023
Categories
Largest genetic study of epilepsy
The largest study on the genetic basis of epilepsy to date is described on the ILAE website in a popular science article (which we strongly recommend reading) along with a brief interview with the authors. The study was published last month in the prestigious journal Nature Genetics and was coordinated by ILAE.
The study involved 30,000 people with epilepsy and more than 50,000 healthy people. Our understanding of why epilepsy arises has been greatly increased by the discovery of a number of new risk genes, which may also aid in the development of novel treatments for the condition.
Original article: GWAS meta-analysis of over 29,000 people with epilepsy identifies 26 risk loci and subtype-specific genetic architecture, Nature Genetics (2023). DOI: 10.1038/s41588-023-01485-w
Categories
WHO: global action plan on epilepsy
An intersectoral global action plan on epilepsy and other neurological disorders has been made fully available on the World Health Organization’s website. The plan has been prepared for the period of 2022-2031.
The plan’s main objective is to increase access to care and treatment for people with epilepsy and other neurological disorders. Additionally, it covers how to raise patient, caregiver, and family quality of life. Activities that support a healthy brain’s development as well as measures to prevent the aforementioned disorders are also promoted.
A report on the celebration of International Epilepsy Day has appeared on the ILAE website. You can read the report at the following link.